Markets rebounded to the green on the sixth anniversary of the bull market boosted by mergers and acquisition activity, and gains in industrial and technology stocks. Benchmarks started the week on an encouraging note after a dismal Friday, when positive jobs data had sparked fears of a sooner-than-expected rate hike. Investors also found a buying opportunity yesterday, after the sell […]
Benchmarks ended in negative territory on Friday as upbeat nonfarm payroll data reignited fears about sooner-than-expected interest rate hike. Meanwhile, the unemployment rate declined to six and a half year low in February. The S&P 500 witnessed its biggest one-day decline in last two months on Friday. Moreover, benchmarks finished in the red for the second consecutive week.For a look […]
If you follow me on Twitter you will have noticed my latest tweet on what to expect during uptrends and downtrends:This is my 17th year trading the markets. The above statement is the essence of what I am experiencing on a daily basis. In order to get exposure to potential super winners you have to identify the right pond to […]
Source: Neuralstem.I haven’t bought these three little-known biotech stocks (yet), but I am watching them closely because I think each of them could have catalysts soon that could move their shares this year. All three are small-market-cap companies that come with risks that are common in this highly speculative pop-and-drop industry, but for investors willing to take a risk, these […]
Dismal monthly car sales report dragged benchmarks down from their record highs in light volume trade on Tuesday. Profit taking also retreated Nasdaq from its key 5K level, a 15-year milestone. Also affecting the markets was Israeli Prime Minister Benjamin Netanyahu’s criticism of White House and Iran’s attempts of a nuclear deal.For a look at the issues currently facing the […]
Benchmarks ended Friday’s trading session in the red as investors weighed positive housing and consumer confidence data against slowdown in the U.S. economic growth. However, benchmarks were able to post their biggest monthly percentage gains in more than two years in February. Strong earnings results by retailers and tech companies, firming up of oil prices, and easing concerns in the […]
Markets remained almost unchanged as Janet Yellen concluded her two-day Congressional testimony before the House Financial Services Committee on Wednesday. In her testimony, Yellen failed to provide enough clues to investors regarding rate hike. Meanwhile, decline in Apple’s shares and dismal earnings results from Hewlett-Packard dragged down technology shares. However, encouraging earnings results from retailers including TJX and Dollar Tree […]
View photo.Biotechnology ETFs have leapt out of the gate in 2015 with another strong spurt of momentum that has catapulted them to the top of sector rankings. The unequivocal asset leader in this category is the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB), which has more than $8 billion under management.IBB has gained more than 12 percent so far this […]
A calm trading session ended with the Dow and S&P 500 slipping into the red as another decline in oil prices affected energy shares. Though these two benchmarks eased off their record highs, the indices were able to erode a chunk of their initial losses following a late-afternoon rally. However, a rally in Apple’s shares propelled Nasdaq to its ninth-straight […]
Fits and starts in developing a revolutionary new inhaled insulin have meant that Al Mann’s MannKind has had more than its fair share of pops and drops over the past few years. MannKind won FDA approval for Afrezza last summer and announced its commercial launch earlier this month . The news has investors wondering if now is a good time […]
